Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis.

Aberrant activation of Wnt signaling is oncogenic and has been implicated in a variety of human cancers. We have developed a doxycycline-inducible Wnt1 transgenic mouse model to determine the dependence of established mammary adenocarcinomas on continued Wnt signaling. Using this model we show that targeted down-regulation of the Wnt pathway results in the rapid disappearance of essentially all Wnt-initiated invasive primary tumors as well as pulmonary metastases. Tumor regression does not require p53 and occurs even in highly aneuploid tumors. However, despite the dependence of primary mammary tumors and metastases on continued Wnt signaling and the dispensability of p53 for tumor regression, we find that a substantial fraction of tumors progress to a Wnt-independent state and that p53 suppresses this process. Specifically, loss of one p53 allele dramatically facilitates the progression of mammary tumors to a Wnt1-independent state both by impairing the regression of primary tumors following doxycycline withdrawal and by promoting the recurrence of fully regressed tumors in the absence of doxycycline. Thus, although p53 itself is dispensable for tumor regression, it nevertheless plays a critical role in the suppression of tumor recurrence. Our findings demonstrate that although even advanced stages of epithelial malignancy remain dependent upon continued Wnt signaling for maintenance and growth, loss of p53 facilitates tumor escape and the acquisition of oncogene independence.

[1]  Kenneth Chu,et al.  Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC , 2002, Science.

[2]  C. Sawyers,et al.  Molecular mechanisms of resistance to STI571 in chronic myeloid leukemia , 2002, Current opinion in hematology.

[3]  Robert B Boxer,et al.  A novel doxycycline‐inducible system for the transgenic analysis of mammary gland biology , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  D. Hicklin,et al.  Effect of p53 Status on Tumor Response to Antiangiogenic Therapy , 2002, Science.

[5]  Scott W. Lowe,et al.  Apoptosis A Link between Cancer Genetics and Chemotherapy , 2002, Cell.

[6]  P. Bendahl,et al.  Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. , 2002, Cancer research.

[7]  R. Cardiff,et al.  Activation of β-catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[8]  H. Varmus,et al.  Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. , 2001, Genes & development.

[9]  D. Birnbaum,et al.  WNT pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type , 2001, Oncogene.

[10]  P. Leder,et al.  β-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland , 2001, Oncogene.

[11]  J. Taipale,et al.  The Hedgehog and Wnt signalling pathways in cancer , 2001, Nature.

[12]  G. Evan,et al.  Proliferation, cell cycle and apoptosis in cancer , 2001, Nature.

[13]  P. Cowin,et al.  Δn89β-Catenin Induces Precocious Development, Differentiation, and Neoplasia in Mammary Gland , 2001, The Journal of cell biology.

[14]  R. Cardiff,et al.  c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations , 2001, Nature Medicine.

[15]  G. Wertheim,et al.  Developmental role of the SNF1-related kinase Hunk in pregnancy-induced changes in the mammary gland. , 2000, Development.

[16]  H. Clevers,et al.  Linking Colorectal Cancer to Wnt Signaling , 2000, Cell.

[17]  P. Polakis.  Wnt signaling and cancer. , 2000, Genes & development.

[18]  W. Muller,et al.  Mammary gland neoplasia: insights from transgenic mouse models , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[19]  H. Varmus,et al.  Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer , 2000, Oncogene.

[20]  H. Clevers,et al.  Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. , 1999, Science.

[21]  K. Kinzler,et al.  Disruption of p53 in human cancer cells alters the responses to therapeutic agents. , 1999, The Journal of clinical investigation.

[22]  D. Felsher,et al.  Reversible tumorigenesis by MYC in hematopoietic lineages. , 1999, Molecular cell.

[23]  L. Chin,et al.  Essential role for oncogenic Ras in tumour maintenance , 1999, Nature.

[24]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[25]  R. Nusse,et al.  Wnt signaling: a common theme in animal development. , 1997, Genes & development.

[26]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[27]  Junzhe Xu,et al.  The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues , 1995, Nature Genetics.

[28]  R. Cardiff,et al.  Histopathology of transgenic mouse mammary tumors (a short atlas). , 1995, Seminars in cancer biology.

[29]  D. Pinkel,et al.  Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. , 1995, Genes & development.

[30]  D. Housman,et al.  p53 status and the efficacy of cancer therapy in vivo. , 1994, Science.

[31]  R. Weinberg,et al.  Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.

[32]  M. Lindstrom,et al.  ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Scott W. Lowe,et al.  p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.

[34]  R. Cardiff,et al.  Transgenic oncogene mice. Tumor phenotype predicts genotype. , 1991, The American journal of pathology.

[35]  H. Varmus,et al.  Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice , 1988, Cell.

[36]  Harold E. Varmus,et al.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome , 1982, Cell.

[37]  L. Vindeløv,et al.  Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions , 1977, Virchows Archiv. B, Cell pathology.

[38]  V. Ll.  Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and straining of nuclei. , 1977 .

[39]  D. Tenen,et al.  Reversibility of acute B-cell leukaemia induced by BCR–ABL1 , 2000, Nature Genetics.

[40]  I. Bergstein,et al.  WNT Genes and Breast Cancer , 1999 .

[41]  D. Pinkel,et al.  The role of p53 loss in genomic instability and tumor progression in a murine mammary cancer model. , 1996, Progress in clinical and biological research.